First Foundation Advisors Abbott Laboratories Transaction History

First Foundation Advisors

$2.58 Billion
Q3 2024

A detailed history of First Foundation Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, First Foundation Advisors holds 10,706 shares of ABT stock, worth $1.24 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,706

Previous 11,141 3.9%

Holding current value

$1.24 Million

Previous $1.16 Million 5.45%

% of portfolio

0.05%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $43,530 - $51,386	-435 Reduced 3.9%	10,706 $1.22 Million
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $31,427 - $35,081	-312 Reduced 2.72%	11,141 $1.16 Million
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $42,384 - $46,811	-387 Reduced 3.27%	11,453 $1.3 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $636,651 - $779,313	-7,059 Reduced 37.35%	11,840 $1.3 Million
Q3 2023 Nov 15, 2023	BUY	$95.53 - $114.62 $189,627 - $227,520	1,985 Added 11.74%	18,899 $1.83 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $364,118 - $405,703	3,613 Added 27.16%	16,914 $1.84 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $2,712 - $3,192	28 Added 0.21%	13,301 $1.35 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $1,520 - $1,784	-16 Reduced 0.12%	13,273 $1.46 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $23,996 - $27,783	248 Added 1.9%	13,289 $1.29 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $12,962 - $15,667	-127 Reduced 0.96%	13,041 $1.42 Million
Q1 2022 May 05, 2022	BUY	$114.02 - $139.04 $195,430 - $238,314	1,714 Added 14.96%	13,168 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $20,679 - $25,321	179 Added 1.59%	11,454 $1.61 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $26,715 - $29,554	229 Added 2.07%	11,275 $1.33 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $1.17 Million - $1.38 Million	11,046 New	11,046 $1.28 Million
Q1 2021 May 18, 2021	SELL	$108.84 - $128.23 $1.18 Million - $1.39 Million	-10,814 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $60,270 - $65,677	-574 Reduced 5.04%	10,814 $1.18 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $118,857 - $144,343	1,297 Added 12.85%	11,388 $1.24 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $147,473 - $188,748	1,926 Added 23.59%	10,091 $923,000
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $13,631 - $19,933	217 Added 2.73%	8,165 $644,000
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $79,138 - $88,099	1,008 Added 14.52%	7,948 $690,000
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $22,915 - $24,847	280 Added 4.2%	6,940 $581,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $56,919 - $66,385	781 Added 13.28%	6,660 $560,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $8,277 - $10,007	125 Added 2.17%	5,879 $470,000
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $8,195 - $9,283	-125 Reduced 2.13%	5,754 $416,000
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $12,709 - $15,332	-209 Reduced 3.43%	5,879 $431,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $1,554 - $1,715	27 Added 0.45%	6,088 $371,000
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $207,467 - $234,566	-3,687 Reduced 37.82%	6,061 $363,000
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $21,472 - $22,988	-400 Reduced 3.94%	9,748 $556,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $11,342 - $12,659	236 Added 2.38%	10,148 $541,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,912	9,912 $482,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.

Account

First Foundation Advisors Abbott Laboratories Transaction History